Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Certification, Funding Debated By White House CAM Commission

This article was originally published in The Tan Sheet

Executive Summary

Alternative funding sources for dietary supplement programs at FDA's Center for Food Safety & Applied Nutrition were floated by members of the White House Commission on Complementary & Alternative Medicine Policy at a meeting in Washington, D.C. March 26.

You may also be interested in...



Supplement GMP Proposed Rule Similar To Third-Party Programs - Lewis

FDA's proposed rule on dietary supplement Good Manufacturing Practices will not deviate significantly from the standards being established by newly-formed third-party certification programs, according to CFSAN Office of Nutritional Products, Labeling & Dietary Supplements Director Christine Lewis, PhD.

FDA Supplement Agenda May Have Tough Critic In Approps/Ag Chair Bonilla

Funding for FDA's dietary supplement initiatives could be hard to come by in FY 2002 if the opinions of House Appropriations/Agriculture Subcommittee Chair Henry Bonilla (R-Tex.) bear any weight.

USP Supplement Certification Program Advisory Group Forming

A USP Industry Advisory Group of representatives from the pharmacopeia, FDA and industry will meet in March to begin finalizing the design of USP's dietary supplement quality certification program.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel